Why calcium, PTH, vitamin D, kidney function, and urine calcium must be interpreted together.
Primary hyperparathyroidism testing starts with a relationship: when blood calcium rises, parathyroid hormone (PTH) should fall. A PTH result that stays elevated—or is not sufficiently suppressed despite being inside the laboratory range—can indicate a parathyroid-driven problem. A single abnormal result does not establish the diagnosis. [1], [2]
An unexpected high blood calcium result, called hypercalcemia, on a comprehensive metabolic panel is often the first clue. The next step is a focused evaluation, not a larger collection of unrelated tests. This guide explains how clinicians connect the blood results, investigate look-alike conditions, and assess the kidneys and bones. [1], [2]
Ulta Lab Tests offers access to many of the blood and urine tests discussed below where available. This article is educational; ordering a test does not replace a clinician’s diagnosis, imaging, bone-density assessment, or treatment plan.
When not to wait: New confusion, fainting, profound weakness, repeated vomiting, inability to stay hydrated, or significant heart-rhythm symptoms with high calcium need urgent medical assessment. A markedly elevated calcium result also warrants prompt clinician contact, even without obvious symptoms. The repeat-testing intervals below are not instructions to delay care. [1], [4]
Primary hyperparathyroidism, or PHPT, occurs when one or more parathyroid glands release PTH inappropriately for the circulating calcium concentration. These small glands are near the thyroid, but they perform a different job: regulating calcium through effects on bone, the kidneys, and vitamin D–dependent intestinal absorption. [1], [2]
The usual cause is a noncancerous growth called an adenoma; sometimes several glands are overactive. Parathyroid cancer is rare. Many people have no obvious symptoms when the condition is discovered. Feeling well does not establish that bone density and kidney health are unaffected. [1]
Primary means the problem originates in the glands. In secondary hyperparathyroidism, the glands increase PTH in response to another problem, such as vitamin D deficiency, reduced kidney function, inadequate calcium intake, or malabsorption. Those situations require different interpretation and management. [2]
Discuss targeted testing with a healthcare professional after an unexplained high calcium result, elevated PTH, recurrent kidney stones, osteoporosis, or a low-trauma fracture—a break after relatively minor trauma. A history of lifelong mild hypercalcemia or relatives with high calcium is also important. [1], [2]
Fatigue, constipation, weakness, thirst, frequent urination, and concentration problems can occur with hypercalcemia, but they are not specific to PHPT. Their presence alone is not a reason to assume a parathyroid disorder or purchase broad hormone, autoimmune, or nutrient panels. Pregnancy with abnormal calcium requires prompt specialist guidance because evaluation and management differ. [1], [2]
Ask whether PTH is appropriate for the calcium level—not simply whether it is flagged high. A reference interval describes results in a comparison population; it does not replace the normal feedback relationship between these two measurements. [1], [5]
| Result pattern | What it may mean | What needs clarification |
|---|---|---|
| High calcium + high PTH | PTH-mediated hypercalcemia; PHPT is an important possibility. | Confirm persistence and consider medications, FHH, and kidney-related context. |
| High calcium + normal-range PTH that is not suppressed | PHPT remains possible despite the absence of a high-PTH flag. | Interpret the paired values, rather than dismissing the pattern as normal. |
| High calcium + suppressed PTH | Points toward a non-PTH cause of hypercalcemia. | Clinician-directed evaluation for other causes; it is not a reason to focus only on the parathyroids. |
| Normal calcium + high PTH | Often a secondary response; normocalcemic PHPT is a diagnosis of exclusion. | Vitamin D, kidney function, calcium intake, malabsorption, medications, and repeated total and ionized calcium. |
| Low calcium + high PTH | An appropriate secondary PTH response to low calcium is more likely than classic hypercalcemic PHPT. | Assess vitamin D, kidney function, magnesium, calcium intake, and absorption according to the clinical history. [5] |
| Mild high calcium + low urinary calcium | FHH is possible, but this pattern also occurs in other settings. | Collection quality, clearance-ratio interpretation, family history, medications, and sometimes genetics. |
These patterns guide evaluation rather than establish a diagnosis on their own. [1], [2] For more about flags, reference intervals, and trends, see How to Read and Understand Your Lab Results.
The core biochemical evaluation connects calcium, albumin, intact PTH, 25-hydroxyvitamin D, phosphorus, and kidney function. Ionized calcium and urine studies answer additional questions when appropriate. The linked tests below are options to discuss with a clinician, not a shopping list that everyone needs. [2]
| Test or option | What it contributes | Important limitation |
|---|---|---|
| Calcium Test and Albumin Test | Total calcium is the initial signal; albumin helps interpret its protein-bound portion. | Abnormal total calcium does not identify the cause. Albumin-based adjustment formulas are estimates. |
| PTH Intact Test | Shows whether the parathyroid response fits the calcium concentration. | Normal-range PTH can be inappropriate with high calcium. Some assays are affected by biotin. |
| Calcium Ionized Test | Measures the unbound, biologically active calcium fraction. | Particularly relevant to suspected normocalcemic disease or discordant total calcium; collection and handling matter. |
| Vitamin D 25-Hydroxy Total Immunoassay Test | Assesses vitamin D status, which can explain or contribute to PTH elevation. | Low vitamin D does not exclude coexisting PHPT. This is different from measuring active 1,25-dihydroxyvitamin D. |
| Phosphate (as Phosphorus) Test | Helps interpret mineral balance; PTH can increase renal phosphorus loss. | Low or low-normal phosphorus is supportive context, not a diagnostic requirement. |
| Creatinine Test or Renal Function Panel Test | Provides kidney-function information; the renal panel also includes calcium, albumin, and phosphorus. | Reduced kidney function may cause secondary PTH elevation. It does not establish that PHPT caused the kidney problem. |
| Comprehensive Metabolic Panel Test - CMP | A broader chemistry option containing calcium, albumin, creatinine, and other chemistry measurements. | It does not include intact PTH, 25-hydroxyvitamin D, or phosphorus. |
| Calcium 24 Hour Urine Test with Creatinine | Measures daily calcium excretion and provides urine creatinine for additional interpretation. | Collection errors and clinical factors affect results. A clearance-ratio calculation also requires appropriately paired blood measurements. |
| Magnesium Test and Alkaline Phosphatase Test | Selected additional tests when mineral disturbances, bone turnover, or another clinical question warrants them. | Neither is specific to PHPT; total alkaline phosphatase can reflect liver as well as bone sources. |
Clinical roles and limitations are based on the guideline and laboratory education sources. [2], [3], [4], [5], [6]
Avoid duplicate components: A Renal Function Panel Test already supplies several chemistry measurements listed separately. A Comprehensive Metabolic Panel Test - CMP overlaps many of them, although it does not include phosphorus. The PTH Intact Test with Ionized Calcium is another combined option when those two measurements are requested. Review existing results and panel contents rather than automatically ordering every standalone test and panel.
Some calcium circulates bound to albumin, while ionized calcium is unbound. Albumin changes can alter total calcium without an equivalent change in its active fraction. The 2022 workshop uses albumin-adjusted calcium in its diagnostic definition. [2], [4]
However, a 2025 study found that commonly used albumin-adjustment formulas could misclassify calcium status and did not consistently outperform unadjusted total calcium. Formulas are therefore not a substitute for clinical interpretation. When albumin is markedly abnormal or results disagree with the clinical picture, a clinician may use the Calcium Ionized Test to clarify the finding. [3]
Inadequate vitamin D can reduce calcium absorption and stimulate PTH. For example, high PTH with normal calcium and a 25-hydroxyvitamin D result of 18 ng/mL may reflect a secondary response. The vitamin D deficiency needs attention and reassessment before assuming normocalcemic PHPT. Primary disease and vitamin D deficiency can also coexist. [2]
In established PHPT, the workshop recommends maintaining 25-hydroxyvitamin D above 30 ng/mL while remaining below the laboratory’s upper limit, with cautious clinician-directed supplementation. This is a disease-management recommendation, not a universal wellness target. Do not self-prescribe high doses to force a laboratory result into range. [2] See the guide to vitamin D tests for the distinction between vitamin D forms.
Kidney disease changes vitamin D activation and mineral handling, which can raise PTH. High PTH with normal calcium and an estimated glomerular filtration rate (eGFR) of 35 mL/min/1.73 m2, for example, makes kidney-related secondary hyperparathyroidism a major consideration. An isolated PTH value cannot distinguish these possibilities. [2]
PHPT can also be associated with stones, calcium deposits, and reduced filtration. The evaluation must separate kidney disease contributing to high PTH from kidney complications occurring alongside PHPT; one does not automatically prove the other. [2] Read Kidney Function Tests for the broader interpretation of filtration and urine markers.
Normocalcemic primary hyperparathyroidism requires persistently elevated PTH with both normal adjusted total calcium and normal ionized calcium, after secondary causes have been excluded. The workshop describes confirmation on at least two occasions over three to six months. [2]
The review includes vitamin D deficiency, chronic kidney disease, low calcium intake, malabsorption, medication effects, and excessive urinary calcium loss. Relevant history includes bariatric surgery and disorders affecting nutrient absorption. Correcting a secondary contributor and documenting what happens afterward can be more informative than repeatedly measuring PTH without addressing its context. [2]
When celiac testing may be relevant: Celiac disease is one possible malabsorption-related explanation for secondary PTH elevation. When symptoms, nutritional deficiencies, or history support that possibility, a clinician may consider a Celiac Disease Comprehensive Panel; this is not routine testing for everyone with high PTH. Discuss testing before starting a gluten-free diet because avoiding gluten can alter the results. People already avoiding gluten should review the diagnostic plan with their clinician rather than restarting gluten independently. [2], [7]
A normal total calcium result alone is insufficient when ionized calcium has not been assessed. Likewise, a high PTH result should not trigger neck imaging before the biochemical explanation is clarified. Surgery criteria developed for hypercalcemic PHPT should not automatically be applied to normocalcemic disease; the workshop found insufficient evidence to establish surgical guidelines for that form. [2]
Review prior results and obtain calcium with albumin and PTH at the same evaluation, together with vitamin D, phosphorus, and kidney-function information. The specific combination of standalone tests and panels should match what is already available and what the clinician needs to clarify. [2]
For hypercalcemic PHPT, the workshop definition requires elevated albumin-adjusted calcium with elevated or inappropriately normal PTH on two occasions at least two weeks apart. Review hydration, illness, supplements, medications, and possible FHH. Use ionized calcium or urine testing when those questions require it. Severe or rapidly worsening abnormalities need faster assessment. [2]
Illustrative trend: With normal, stable albumin and a sample calcium reference range of 8.6–10.2 mg/dL, calcium results of 10.7 and 10.8 mg/dL three weeks apart would both be elevated. PTH results of 62 and 65 pg/mL might remain within a sample range of 15–65 pg/mL, yet still be inappropriate for those calcium levels. These illustrative values show persistence—not proof of PHPT or meaningful progression from a small numerical change.
When PHPT is established or strongly suspected, investigate urinary calcium and relevant mimics, kidney stones or calcium deposits, bone density, and vertebral fractures. These assessments can change management even when serum calcium is only mildly elevated. [2]
An endocrinologist or other qualified clinician integrates the findings, with an experienced parathyroid surgeon when appropriate. Follow-up is based on the diagnosis and risk—not on automatically repeating every test in the original workup. [2]
The Calcium 24 Hour Urine Test with Creatinine helps quantify calcium excretion over a full day. It can contribute to stone-risk evaluation and to distinguishing PHPT from familial hypocalciuric hypercalcemia, or FHH, an inherited calcium-sensing disorder that often causes lifelong mild hypercalcemia with relatively low urinary calcium. [2], [6]
Urine creatinine helps assess whether a collection is plausible, but it does not guarantee that every void was collected. The amount of calcium excreted also depends on kidney function, vitamin D, diet, sodium intake, and medications. One abnormal urine result does not identify the cause of hypercalcemia. [2], [6]
The calcium-to-creatinine clearance ratio, or CCCR, uses urine calcium and creatinine together with corresponding serum calcium and creatinine. A simple urine calcium/creatinine ratio, or the total calcium excreted per day, is not interchangeable with CCCR. Coordinate the urine collection and blood measurements with the ordering clinician. [2]
A CCCR below 0.01 favors FHH; 0.01–0.02 is an overlapping range; and values above 0.02 generally favor PHPT. However, people with PHPT can have low ratios, and people with FHH can have higher ones. No single threshold reliably separates everyone. [2]
Vitamin D deficiency, chronic kidney disease, thiazides, lithium, low calcium intake, and incomplete collection can complicate interpretation. Lifelong results and family history may be as important as the cutoff. Selected patients need genetic evaluation before surgery is considered, because parathyroid surgery generally does not correct the underlying calcium abnormality in FHH. [2]
Urine calcium above 250 mg/day in women or 300 mg/day in men is a renal surgery criterion in the workshop’s framework for confirmed hypercalcemic PHPT. These are management thresholds in that setting—not proof that PHPT caused every elevated urine-calcium result. [2]
A stable or mildly elevated calcium result does not describe the entire disease. Kidney stones and skeletal changes can be present without prominent symptoms. Blood and urine tests cannot replace the imaging needed to identify them. [1], [2]
Kidney evaluation includes renal-function assessment and, as appropriate to the PHPT workup, imaging for stones or nephrocalcinosis, meaning calcium deposits in kidney tissue. People with stones or hypercalciuria may need a broader stone-risk evaluation because urinary calcium is only one contributor. [2]
When urinalysis adds information: When stones, blood in the urine, or other urinary symptoms are part of the clinical picture, a clinician may include a Urinalysis Complete Test to look for blood and other urinary abnormalities. This is symptom-directed testing, not a diagnostic test for PHPT and not a substitute for the Calcium 24 Hour Urine Test with Creatinine or kidney imaging. [8]
Bone evaluation uses dual-energy X-ray absorptiometry (DXA), a bone-density scan, at the lumbar spine, hip, and distal one-third radius. The radius matters because PHPT can particularly affect cortical bone, the hard outer layer of bone. Vertebral fracture assessment or spine imaging can reveal fractures not explained by the spine’s bone-density value alone. [2]
Two illustrative examples: A postmenopausal patient with confirmed PHPT and a distal-radius T-score of −2.7 has an important skeletal finding even when lumbar-spine density looks reassuring. Another patient may have only mild hypercalcemia but a kidney stone on imaging. Either finding can support surgery under the appropriate guideline criteria. [2]
For the broader causes and evaluation of bone loss, see the osteoporosis and bone-density guide. Laboratory measurements of calcium or alkaline phosphatase are not substitutes for DXA.
Parathyroidectomy is the only definitive curative treatment for PHPT. Surgery is recommended for symptomatic disease and for appropriately diagnosed, otherwise asymptomatic hypercalcemic PHPT when one or more of the following criteria is present, provided there is no contraindication. Decisions belong with the patient and qualified clinical team. [2]
| Finding | Fifth International Workshop criterion |
|---|---|
| Serum calcium | More than 1.0 mg/dL above the laboratory’s upper limit of normal. |
| Skeletal involvement | A vertebral fracture on assessment/imaging, or bone density with a T-score of −2.5 or lower at an evaluated site. |
| Reduced kidney function | eGFR below 60 mL/min/1.73 m2, or creatinine clearance below 60 mL/min. |
| Kidney stones or deposits | Nephrolithiasis or nephrocalcinosis on imaging. |
| High urinary calcium | More than 250 mg/day in women or more than 300 mg/day in men. |
| Age | Younger than 50 years. |
The table summarizes the 2022 workshop’s hypercalcemic PHPT recommendations. T-scores are used for postmenopausal women and men age 50 or older; younger adults require age-appropriate bone-density interpretation and already meet the age criterion when PHPT is confirmed. A fragility fracture also deserves specialist assessment. [2]
Surgery can remain an option without these findings after shared decision-making. Conversely, meeting a numerical threshold does not replace confirmation of PHPT and investigation of important alternatives such as FHH. Fatigue, “brain fog,” or cardiovascular findings alone do not establish that surgery will improve those problems. [2]
Neck ultrasound, sestamibi scanning, and four-dimensional CT are localization tools used to plan an operation. They do not establish or exclude PHPT. A negative scan does not erase a biochemical diagnosis, and an apparent parathyroid nodule does not prove one. This differs from kidney imaging, which assesses complications rather than locating a gland. [2]
For appropriately selected patients managed without surgery, the workshop distinguishes routine surveillance from studies ordered for a specific indication. The goal is to detect changes that affect management, not simply document that calcium remains high. [2]
| Assessment | Usual workshop-based follow-up |
|---|---|
| Calcium Test and Vitamin D 25-Hydroxy Total Immunoassay Test | Annually, with earlier checks when the clinical situation or treatment requires them. |
| Kidney function | Annually. The workshop prefers creatinine clearance where practical; a clinician may use Creatinine Clearance or creatinine-based eGFR as appropriate. |
| PTH Intact Test | When clinically indicated—not automatically every time calcium is measured. |
| Three-site DXA | About every one to two years; the interval can differ when bone density is normal or circumstances change. |
| Kidney imaging, vertebral imaging, and Calcium 24 Hour Urine Test with Creatinine | When clinically indicated, rather than an automatic annual requirement for every patient. |
A measured creatinine-clearance study requires its own timed-urine and blood arrangements; it is not the same as an eGFR estimate or a urine-calcium collection alone. Follow the exact order instructions.
Reassess the management plan if calcium consistently exceeds the surgical threshold, a low-trauma fracture or kidney stone develops, bone density declines significantly into the osteoporosis range, or kidney function meaningfully worsens. A small laboratory fluctuation is not automatically progression. New problems need evaluation rather than an assumption that PHPT explains them all. [2]
Do not assume high blood calcium means dietary calcium should be severely restricted. In PHPT, marked restriction can stimulate more PTH. The workshop advises normal nutritional calcium intake and cautious correction of vitamin D deficiency, with amounts individualized to results, kidney health, stone history, and clinician guidance. [2]
Medication choices address different problems when surgery is not performed. Cinacalcet can lower calcium, whereas selected bone-directed medicines can improve bone density; neither is equivalent to removing the abnormal gland tissue. These decisions require medical supervision, not self-treatment based on a laboratory flag. [2] Broader nutrition questions belong in Vitamin and Nutrient Deficiency Tests, rather than an expanded PHPT test panel.
Use the instructions for the exact tests ordered. Fasting, collection timing, specimen handling, and urine-storage requirements are not identical for every test or panel. Maintain usual hydration unless your clinician has prescribed a fluid restriction or different instructions. [4], [5], [6]
Provide a complete list of medicines and supplements, including thiazides, lithium, calcium, vitamin D, calcium-containing antacids, osteoporosis medicines, and biotin. Biotin can produce falsely low PTH in some assays. Ask the laboratory and clinician about preparation rather than applying a universal supplement pause or stopping prescribed treatment yourself. [2]
For a timed urine collection, obtain the correct kit first and follow its start time, end time, and storage directions. Collect every required void during the specified period. Report missed samples or timing errors instead of assuming the collection can still be interpreted normally. Ask whether blood tests need to be coordinated with the collection. [6]
Is my PTH appropriate for my calcium? Could vitamin D, kidney disease, intake, medicines, or FHH explain the pattern? Do I need ionized calcium, paired urine and blood measurements, kidney imaging, or three-site DXA? Which results would change the plan, and which tests actually need repeating?
Ulta Lab Tests provides online access to many relevant blood and urine tests where available, with pricing displayed before ordering and results available through the patient account. Review the requested components and collection instructions before checkout. The Direct-Access Lab Testing: How It Works and What to Expect guide explains the ordering, authorization, collection, and results process.
Start with the clinical question and existing records. A PTH Intact Test, Calcium Test, Vitamin D 25-Hydroxy Total Immunoassay Test, or Calcium 24 Hour Urine Test with Creatinine may answer a specific question when selected appropriately; purchasing all of them does not itself establish a diagnosis. Share results with the clinician who can interpret them alongside imaging, medication history, and prior measurements.
Yes. A result can fall inside the laboratory interval yet remain too high for an elevated calcium level. Clinicians call this “inappropriately normal” PTH. It supports further evaluation, not an automatic diagnosis, because the paired pattern must be confirmed and other explanations considered. [1], [2]
No. Albumin, hydration, medicines, supplements, illness, and non-parathyroid causes can affect interpretation. The workshop’s hypercalcemic PHPT definition requires qualifying calcium–PTH measurements on two occasions at least two weeks apart. Markedly high calcium or concerning symptoms requires prompt assessment rather than waiting for that interval. [2], [4]
A Comprehensive Metabolic Panel Test - CMP can reveal high calcium and provide albumin and kidney markers, but it does not include PTH. It cannot establish PHPT by itself. The evaluation usually needs a PTH Intact Test and relevant mineral and vitamin D information, with additional testing selected according to the findings. [2]
Yes. Vitamin D deficiency can stimulate PTH even when calcium is normal. It can also coexist with PHPT. Measuring vitamin D helps distinguish these situations, but supplement doses and reassessment should be clinician-directed, particularly when calcium is already high or there is a history of kidney stones. [2]
No. FHH is one explanation, but vitamin D deficiency, kidney disease, medicines, intake, and collection problems also matter. The clearance ratio uses both blood and urine measurements and has substantial overlap between FHH and PHPT. Selected patients need genetic evaluation before a surgical decision. [2]
No. PHPT is established through biochemical and clinical evaluation, not a neck scan. Localization imaging is generally obtained after surgery has been selected to help plan the procedure. A negative localization study can occur despite PHPT and should be interpreted by the treating clinical team. [2]
No. For appropriate observation without surgery, annual calcium, vitamin D, and kidney assessment are distinguished from PTH, urine studies, and imaging ordered when indicated. DXA is generally considered every one to two years. Your schedule can change with new symptoms, treatment, or evidence of progression. [2]
Renewed hypercalcemia deserves clinical evaluation rather than an assumption that surgery rules out future problems. The clinician reviews calcium with PTH, postoperative history, medicines, supplements, and other possible causes. Depending on timing and findings, persistent or recurrent PHPT may be considered. Do not restart treatment independently. [2]
Primary hyperparathyroidism testing is most useful when calcium and PTH are interpreted together. Vitamin D, kidney function, medications, and urinary calcium help distinguish competing explanations. Kidney imaging and bone-density assessment reveal consequences that blood tests alone cannot show. Serial results help determine whether the chosen management plan remains appropriate. [1], [2]
Explore the linked laboratory options with your healthcare provider, select only the tests needed for the next clinical question, and use the results to guide follow-up—not to substitute for it.
Laboratory fundamentals: The Complete Guide to Lab Tests and Blood Work; How to Read and Understand Your Lab Results; Direct-Access Lab Testing: How It Works and What to Expect.
Related health areas: Kidney Function Tests; Vitamin and Nutrient Deficiency Tests; Healthy Aging and Longevity Blood Tests. These broader guides complement the condition-specific evaluation above.
The diagnostic definitions, surgical criteria, and monitoring intervals above identify the Fifth International Workshop’s 2022 recommendations. The discussion of albumin-adjustment limitations also incorporates the separate 2025 study listed below.
Medical disclaimer: This content is for education and is not personal medical advice. Laboratory testing does not replace evaluation, diagnosis, or treatment by a qualified healthcare professional. Seek urgent care for severe or rapidly worsening symptoms.
| Linked test | Role in the article |
|---|---|
| Calcium Test | Total blood calcium: the starting result interpreted alongside PTH and the wider clinical picture. |
| Albumin Test | Protein context for interpreting total calcium. |
| PTH Intact Test | Evaluation of whether the parathyroid hormone response is appropriate for the calcium result. |
| Calcium Ionized Test | Measurement of unbound calcium when clarification is needed, including suspected normocalcemic disease. |
| Phosphate (as Phosphorus) Test | Supporting mineral-balance information interpreted with calcium, PTH, and kidney function. |
| Linked test | Role in the article |
|---|---|
| Vitamin D 25-Hydroxy Total Immunoassay Test | Vitamin D status, including its role in secondary PTH elevation and interpretation of a possible PHPT pattern. |
| Magnesium Test | Selected additional testing when mineral disturbances or another clinical indication warrants it. |
| Alkaline Phosphatase Test | Selected supporting assessment; total alkaline phosphatase is not specific to bone or PHPT. |
| Linked test | Role in the article |
|---|---|
| Creatinine Test | Kidney-function information relevant to both PTH interpretation and follow-up. |
| Creatinine Clearance | A measured clearance assessment when selected by the clinician; distinct from a creatinine-based eGFR estimate. |
| Calcium 24 Hour Urine Test with Creatinine | Daily calcium excretion and urine creatinine, contributing to hypercalciuria, stone-risk, and FHH evaluation. |
| Urinalysis Complete Test | Symptom-directed assessment when blood in the urine, stones, or other urinary findings warrant investigation. |
| Linked test or panel | Role in the article |
|---|---|
| Comprehensive Metabolic Panel Test - CMP | A broader chemistry option that includes calcium, albumin, and creatinine. |
| Renal Function Panel Test | A kidney-focused chemistry option that includes several separately discussed measurements, including calcium, albumin, and phosphorus. |
| PTH Intact Test with Ionized Calcium | A combined option when both intact PTH and ionized calcium are requested. |
| Linked test | Role in the article |
|---|---|
| Celiac Disease Comprehensive Panel | A conditional option when symptoms, nutritional findings, or history support investigating celiac-related malabsorption as an explanation for secondary PTH elevation. |
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
